tirzepatide weight loss timeline Our management program: 12 months of semaglutide, 7 months of Weight Loss Shots | Cordova

Switching typically takes 12-16 weeks to fully retitrate

Their role is essential in delivering the high-quality, patient-first service that sets Affinity Whole Health apart

However, CMS clarified in a memo dated March 20, 2024, that anti-obesity medications that receive FDA approval for an additional medically accepted indication can be considered a Part D drug for that specific use. As of August 19, 2024, the only GLP-1 RA this applies to is Wegovy, which, in addition to its obesity indication, is also indicated to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight

Patients should consult a provider before making any dose changes, especially if they experience side effects or have concerns about effectiveness

[DOI] [PMC free article] [PubMed] [Google Scholar] 20.Yang A.M., Cui N., Sun Y.F., Hao G.M

The Bottom Line For patients and clinicians, the choice between these therapies depends on: Desired weight loss Convenience and preference (oral vs injectable) Tolerance of side effects Insurance and accessibility Retatrutide leads in efficacy but may bring more side effects